1. Deng, Houliang, Guan, Xiaowen, Gong, Longcai, Chen, Mike Y, Li, Gang. 2019. CBX6 is negatively regulated by EZH2 and plays a potential tumor suppressor role in breast cancer. In Scientific reports, 9, 197. doi:10.1038/s41598-018-36560-4. https://pubmed.ncbi.nlm.nih.gov/30655550/
2. Li, Xinxin, Li, Lili, Xiong, Xi, Zhu, Kai, Luo, Pengcheng. 2023. Identification of the Prognostic Biomarkers CBX6 and CBX7 in Bladder Cancer. In Diagnostics (Basel, Switzerland), 13, . doi:10.3390/diagnostics13081393. https://pubmed.ncbi.nlm.nih.gov/37189494/
3. Sakai, Katsuya, Nishiuchi, Takumi, Tange, Shoichiro, Suzuki, Takeshi, Matsumoto, Kunio. 2020. Proteasomal degradation of polycomb-group protein CBX6 confers MMP-2 expression essential for mesothelioma invasion. In Scientific reports, 10, 16678. doi:10.1038/s41598-020-72448-y. https://pubmed.ncbi.nlm.nih.gov/33028834/
4. Santanach, Alexandra, Blanco, Enrique, Jiang, Hua, Morey, Lluis, Di Croce, Luciano. 2017. The Polycomb group protein CBX6 is an essential regulator of embryonic stem cell identity. In Nature communications, 8, 1235. doi:10.1038/s41467-017-01464-w. https://pubmed.ncbi.nlm.nih.gov/29089522/
5. Pan, Ziwen, Chang, Sheng, Chen, Song, Chen, Zhishui, Zhang, Weijie. 2024. Identification of Cbx6 as a potential biomarker in renal ischemia/reperfusion injury. In Transplant immunology, 84, 102018. doi:10.1016/j.trim.2024.102018. https://pubmed.ncbi.nlm.nih.gov/38452983/
6. Li, Gang, Warden, Charles, Zou, Zhaoxia, Jandial, Rahul, Chen, Mike. 2013. Altered expression of polycomb group genes in glioblastoma multiforme. In PloS one, 8, e80970. doi:10.1371/journal.pone.0080970. https://pubmed.ncbi.nlm.nih.gov/24260522/
7. de Groot, Anne P, de Haan, Gerald. 2024. How CBX proteins regulate normal and leukemic blood cells. In FEBS letters, 598, 2788-2806. doi:10.1002/1873-3468.14839. https://pubmed.ncbi.nlm.nih.gov/38426219/
智鼠故事 
